Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Wiss. Mitarbeiter/in und Wiss. Assistent/in, Institut für Virologie
Aktuelle Veranstaltungen
-
SoSe 2025
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
A Variety of Mouse PYHIN Proteins Restrict Murine and Human RetrovirusesIn: Viruses , Jg. 16 2024, Nr. 4, 493DOI (Open Access)
-
Filling two needs with one deed : A combinatory mucosal vaccine against influenza A virus and respiratory syncytial virusIn: Frontiers in Immunology , Jg. 15 2024, 1376395DOI (Open Access)
-
Longitudinal Analysis of Binding Antibody Levels Against 39 Human Adenovirus Types in Sera from 60 Regular Blood Donors from Greifswald, Germany, over 5 Years from 2018 to 2022In: Viruses , Jg. 16 2024, Nr. 11, 1747DOI, Online Volltext (Open Access)
-
Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastasesIn: Journal for ImmunoTherapy of Cancer , Jg. 12 2024, Nr. 3, e008652DOI (Open Access)
-
Seroprevalence of binding and neutralizing antibodies against 18 adeno-associated virus types in patients with neuromuscular disordersIn: Frontiers in Immunology , Jg. 15 2024, 1450858DOI, Online Volltext (Open Access)
-
Comparative analysis of the impact of 40 adenovirus types on dendritic cell activation and CD8⁺ T cell proliferation capacity for the identification of favorable immunization vector candidatesIn: Frontiers in Immunology , Jg. 14 2023, 1286622DOI, Online Volltext (Open Access)
-
Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell folliclesIn: PLoS Pathogens , Jg. 19 2023, Nr. 10, e1011725DOI (Open Access)
-
Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular DisordersIn: Viruses , Jg. 15 2023, Nr. 1, 79DOI, Online Volltext (Open Access)
-
A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host responseIn: Retrovirology , Jg. 19 2022, Nr. 1, 29DOI, Online Volltext (Open Access)
-
Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 PandemicIn: Journal of Virology , Jg. 96 2022, Nr. 22, e0113322
-
COVID-19 vaccination and HIV-1 acquisitionIn: Lancet , Jg. 399 2022, Nr. 10333, S. e34 – e35DOI (Open Access)
-
Changes in Symptoms Experienced by SARS-CoV-2-Infected Individuals : From the First Wave to the Omicron VariantIn: Frontiers in Virology , Jg. 2 2022, 880707DOI, Online Volltext (Open Access)
-
Immune suppression of vaccine-induced CD8⁺ T cell-responses by gamma retrovirus envelope is mediated by interleukin-10 producing CD4⁺ T cellsIn: Frontiers in Immunology , Jg. 13 2022, 934399DOI, Online Volltext (Open Access)
-
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular AtrophyIn: Human Gene Therapy , Jg. 33 2022, Nr. 17-18, S. 968 – 976
-
The Role of the Inhibitory Ligand HVEM and Its Receptors CD160 and BTLA in the Regulation of Anti-retroviral T Cell ResponsesIn: Frontiers in Virology , Jg. 2 2022, 836291DOI, Online Volltext (Open Access)
-
Comparative evaluation of the vaccine efficacies of three adenovirus-based vector types in the friend retrovirus infection modelIn: Journal of Virology , Jg. 93 2019, Nr. 21, S. e01155 – 19DOI (Open Access)
-
Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B CellsIn: mBio , Jg. 10 2019, Nr. 1, S. e02578 – 18DOI (Open Access)
-
Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend VirusIn: Viruses , Jg. 11 2019, Nr. 2, S. 145DOI (Open Access)
-
Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infectionIn: PLoS Pathogens , Jg. 15 2019, Nr. 9, e1008043DOI (Open Access)
-
Infection of B Cell Follicle-Resident Cells by Friend Retrovirus Occurs during Acute Infection and Is Maintained during Viral PersistenceIn: mBio , Jg. 10 2019, Nr. 1DOI (Open Access)
-
MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearanceIn: Journal of Hepatology , Jg. 71 2019, Nr. 4, S. 685 – 698
-
IL-1β as mucosal vaccine adjuvant : the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A virusesIn: Mucosal Immunology , Jg. 11 2018, Nr. 4, S. 1265 – 1278DOI (Open Access)
-
Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral InfectionIn: Frontiers in Immunology , Jg. 9 2018, 614DOI (Open Access)
-
Immunodominance of Adenovirus-Derived CD8+ T Cell Epitopes Interferes with the Induction of Transgene-Specific Immunity in Adenovirus-Based ImmunizationIn: Journal of Virology , Jg. 91 2017, Nr. 20, S. e01184 – 17DOI (Open Access)
-
Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine deliveryIn: Retrovirology , Jg. 14 2017, Nr. 1, 8DOI (Open Access)
-
Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectorsIn: Retrovirology , Jg. 14 2017, Nr. 1, 28DOI (Open Access)
-
Broad and potent antiviral activity of the NAE inhibitor MLN4924In: Scientific Reports , Jg. 6 2016, 19977DOI (Open Access)
-
Combination of nanoparticle‑based therapeutic vaccination and transient ablation of regulatory T cells enhances anti‑viral immunity during chronic retroviral infectionIn: Retrovirology , Jg. 13 2016, 24DOI (Open Access)
-
Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 NexusIn: Cell Reports , Jg. 17 2016, Nr. 6, S. 1571 – 1583DOI (Open Access)
-
Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speedIn: The Journal of Immunology (JI) , Jg. 193 2014, Nr. 4, S. 1567 – 1577DOI (Open Access)
-
Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infectionIn: Nanomedicine: Nanotechnology, Biology, and Medicine , Jg. 10 2014, Nr. 8, S. 1787 – 1798
-
Comparison of polystyrene nanoparticles and UV-inactivated antigen-displaying adenovirus for vaccine delivery in miceIn: Virology Journal , Jg. 10 2013, 108DOI (Open Access)
-
Das überlistete Immunsystem : Viren tricksen das Immunsystem aus, um chronische Infektionen zu etablierenIn: Unikate: Berichte aus Forschung und Lehre 2013, Nr. 44: Medizin : 50 Jahre Universitätsklinikum Essen, S. 32 – 41DOI, Online Volltext (Open Access)
-
Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infectionIn: PLoS ONE , Jg. 8 2013, Nr. 12, S. e82528DOI (Open Access)
-
Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infectionIn: Journal of Virology , Jg. 86 2012, Nr. 3, S. 1706 – 1716
-
Modification of One Epitope-Flanking Amino Acid Allows for the Induction of Friend Retrovirus-Specific CD8+ T Cells by Adenovirus-Based ImmunizationIn: Journal of Virology , Jg. 86 2012, Nr. 22, S. 12422 – 12425
-
Distinct roles of CD4+ T cell subpopulations in retroviral immunity : lessons from the Friend virus mouse model.In: Retrovirology , Jg. 8 2011, 76DOI, Online Volltext (Open Access)
-
Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.In: Retrovirology , Jg. 8 2011, Nr. 1, 75DOI, Online Volltext (Open Access)
-
Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4⁺ T-cell responses and confers enhanced protectionIn: Journal of Virology , Jg. 84 2010, Nr. 4, S. 1967 – 1976
-
Interview with a Retrovirologist : Wibke Bayer in conversation with Hung FanIn: Retrovirology , Jg. 19 2022, Nr. 1, 14DOI (Open Access)
-
Novel adenovirus vaccine vectors lacking binding to the thrombosis associated Platelet Factor 4 protein
ESGCT 31st Annual Congress In collaboration with SITGEC; 22-25, 2024; Rome, Italy,In: Human Gene Therapy , Jg. 36 2025, Nr. 3-4, S. e129 – e557DOI (Open Access) -
Effective immunmodulation by biodegradable calcium phosphate nanoparticles confers strong antiviral protection
65th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM), 22.-25.09.2013, Rostock,In: International Journal of Medical Microbiology (IJMM) , Jg. 303 2013, Nr. Suppl. 1, S. 38 – 38 -
Adenovirus-basierte Immunisierungen gegen Retroviren : Strategien zur OptimierungDuisburg ; Essen 2020